Dr Margaret Annette Nelson, DR MARGARET NELSON | |
2389 E.f Griffin Road, Bartow, FL 33830 | |
(863) 701-5428 | |
Not Available |
Full Name | Dr Margaret Annette Nelson |
---|---|
Gender | Female |
Speciality | Marriage & Family Therapist |
Location | 2389 E.f Griffin Road, Bartow, Florida |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679821813 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | LCMFT0351010512 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Margaret Annette Nelson, DR MARGARET NELSON 2389 G.f Griffin Road, Bartow, FL 33830 Ph: (863) 701-5428 | Dr Margaret Annette Nelson, DR MARGARET NELSON 2389 E.f Griffin Road, Bartow, FL 33830 Ph: (863) 701-5428 |
News Archive
New research shows that Caucasian women may suffer from restless legs syndrome (RLS), a sleep disorder characterized by the strong urge to move the legs, up to four times more than African-American women. The study, presented at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP), found that, overall, non-African-American (NAA) patients experienced RLS four times more often than African-Americans (AA).
According to a new case report patients receiving radioactive isotopes should be warned that they may trigger radiation alarms for several weeks after the treatment has been completed.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced preclinical data which demonstrate that its Notch1-specific monoclonal antibody is a highly potent inhibitor of Notch1 function in both in vitro and in vivo models. These data were presented today at the American Association for Cancer Research (AACR) 101st Annual Meeting 2010 in Washington, D.C.
Mayo Clinic researchers, working with colleagues at the University of Minnesota and University of Pittsburgh, are the first to describe a new role for a specialized cell of the immune system in children suffering from a rare muscle-damaging disease known as juvenile dermatomyositis (JDM).
Following the broadcast on CTV's W5 of the plight of multiple myeloma patient Frank Boyd and his inability to obtain appropriate drug treatment, on March 27, the President of Myeloma Canada, John Lemieux, immediately wrote to the Honourable Maureen MacDonald, Minister of Health of Nova Scotia urging her to implement an interim arrangement to ensure that Revlimid is available to multiple myeloma patients, including Mr. Boyd, in Nova Scotia.
› Verified 9 days ago